Hmox1 and Cdh1 are pivotal biomarkers for bisphenol-induced POI, modulating apoptosis and endocrine resistance. These targets offer novel therapeutic avenues for environmental toxin-related ovarian dysfunction.
Shi et al. (Sun,) studied this question.